Literature DB >> 17728288

Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality.

Mari-Ann Wallander1, Saga Johansson, Ana Ruigómez, Luis Alberto García Rodríguez, Roger Jones.   

Abstract

BACKGROUND: Many individuals consulting their GP with upper abdominal symptoms are initially classified as having dyspepsia. Few studies have described the incidence of dyspepsia or the comorbidities, risk factors or prognosis associated with this diagnosis.
METHODS: We used the UK General Practice Research Database to find patients with a new diagnosis of dyspepsia in 1996 (n = 6,913) and a control cohort (n = 11,036). We determined the incidence of dyspepsia, potential risk factors and comorbidity, and the risk of new onset morbidity in the year following the index date.
RESULTS: The incidence of dyspepsia was 15.3 per 1,000 person-years. An increased probability of a dyspepsia diagnosis was associated with chest pain [odds ratio (OR): 2.4], general pain (OR: 1.8), sleep disorders (OR: 1.5), angina (OR: 1.5), osteoarthritis/rheumatoid arthritis (OR: 1.4) and smoking (OR: 1.2). There was only a borderline association with obesity (OR: 1.1). Patients with dyspepsia had an increased likelihood of a diagnosis of irritable bowel syndrome (IBS) (OR: 264), gastroesophageal reflux disease (GERD) (OR: 62.8) or peptic ulcer disease (PUD) (OR: 27.2) during the following year.
CONCLUSIONS: The commonest diagnosis to emerge after an initial consultation for dyspepsia was IBS, followed by GERD and PUD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728288     DOI: 10.1093/fampra/cmm050

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  16 in total

1.  Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population.

Authors:  Richard A Brook; Nathan L Kleinman; Rok Seon Choung; James E Smeeding; Nicholas J Talley
Journal:  Dig Dis Sci       Date:  2011-07-13       Impact factor: 3.199

2.  The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.

Authors:  Orlaith B Kelly; Catherine Dillane; Stephen E Patchett; Gavin C Harewood; Frank E Murray
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

Review 3.  Persistent and de novo symptoms after cholecystectomy: a systematic review of cholecystectomy effectiveness.

Authors:  Mark P Lamberts; Marjolein Lugtenberg; Maroeska M Rovers; Anne J Roukema; Joost P H Drenth; Gert P Westert; Cornelis J H M van Laarhoven
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

4.  Influence of various factors on functional dyspepsia.

Authors:  Barbara Ebling; Dragan Jurcic; Karolina Majstorovic Barac; Ante Bilic; Iva Bajic; Miran Martinac; Sandra Pribic; Aleksandar Vcev
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

5.  Impact of functional gastrointestinal disorders on survival in the community.

Authors:  Joseph Y Chang; G Richard Locke; Meredythe A McNally; Smita L Halder; Cathy D Schleck; Alan R Zinsmeister; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2010-02-16       Impact factor: 10.864

6.  Primary prevention, aging, and cancer: overview and future perspectives.

Authors:  Suzanne M Miller; Deborah J Bowen; Jennifer Lyle; Melissa Clark; David Mohr; Jane Wardle; Rachel Ceballos; Karen Emmons; Ellen Gritz; Laura Marlow
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

7.  Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications.

Authors:  Hye-Kyung Jung; Rok Seon Choung; Nicholas J Talley
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 8.  The chronic gastrointestinal consequences associated with campylobacter.

Authors:  Mark S Riddle; Ramiro L Gutierrez; Elena F Verdu; Chad K Porter
Journal:  Curr Gastroenterol Rep       Date:  2012-10

9.  Body mass index association with functional gastrointestinal disorders: differences between genders. Results from a study in a tertiary center.

Authors:  Michel Bouchoucha; Marinos Fysekidis; Chantal Julia; Gheorghe Airinei; Jean-Marc Catheline; Régis Cohen; Robert Benamouzig
Journal:  J Gastroenterol       Date:  2015-08-12       Impact factor: 7.527

10.  The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.

Authors:  Douglas Mapel; Melissa Roberts; Andrew Overhiser; Andrew Mason
Journal:  Helicobacter       Date:  2012-09-04       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.